203 related articles for article (PubMed ID: 8624258)
1. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival.
Soini Y; Virkajärvi N; Lehto VP; Pääkkö P
Br J Cancer; 1996 May; 73(9):1025-30. PubMed ID: 8624258
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Osada S; Saji S; Kuno T
J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
[TBL] [Abstract][Full Text] [Related]
3. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma.
Törmänen U; Eerola AK; Rainio P; Vähäkangas K; Soini Y; Sormunen R; Bloigu R; Lehto VP; Pääkkö P
Cancer Res; 1995 Dec; 55(23):5595-602. PubMed ID: 7585640
[TBL] [Abstract][Full Text] [Related]
4. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
Saiki I; Une Y; Uchino J
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
[TBL] [Abstract][Full Text] [Related]
5. Association between p53 overexpression, cell proliferation, tumor necrosis and extent of apoptosis in operated pancreatic adenocarcinoma.
Virkajärvi N; Pääkkö P; Soini Y
APMIS; 1997 Oct; 105(10):765-72. PubMed ID: 9368591
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
Paiva C; Oshima CT; Lanzoni VP; Forones NM
Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
[TBL] [Abstract][Full Text] [Related]
7. Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis.
Soini Y; Virkajärvi N; Raunio H; Pääkkö P
J Clin Pathol; 1996 Jun; 49(6):470-3. PubMed ID: 8763260
[TBL] [Abstract][Full Text] [Related]
8. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
[TBL] [Abstract][Full Text] [Related]
9. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.
Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C
J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104
[TBL] [Abstract][Full Text] [Related]
11. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
[TBL] [Abstract][Full Text] [Related]
13. The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer.
Tjalma WA; Weyler JJ; Bogers JJ; Pollefliet C; Baay M; Goovaerts GC; Vermorken JB; van Dam PA; van Marck EA; Buytaert PM
Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):223-30. PubMed ID: 11451553
[TBL] [Abstract][Full Text] [Related]
14. Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma.
Wu PC; Lau VK; Fang JW; Lai VC; Lai CL; Lau JY
Liver; 1999 Oct; 19(5):444-51. PubMed ID: 10533805
[TBL] [Abstract][Full Text] [Related]
15. PCNA, Ki-67, p53, bcl-2 and prognosis in intraoral squamous cell carcinoma of the head and neck.
Nylander K; Schildt EB; Eriksson M; Roos G
Anal Cell Pathol; 1997; 14(2):101-10. PubMed ID: 9313825
[TBL] [Abstract][Full Text] [Related]
16. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
17. Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung.
Eerola AK; Ruokolainen H; Soini Y; Raunio H; Pääkkö P
Pathol Oncol Res; 1999; 5(3):179-86. PubMed ID: 10491014
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and cell proliferation: correlation with BCL-2 and P53 oncoprotein expression in human hepatocellular carcinoma.
EI-Emshaty HM; Saad EA; Toson EA; Abdel Malak CA; Gadelhak NA
Hepatogastroenterology; 2014; 61(133):1393-401. PubMed ID: 25436317
[TBL] [Abstract][Full Text] [Related]
19. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
20. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]